Skip to content
GQINewsNews Archive 2026News Archive 2025News Archive 2024News Archive 2023News Archive 2022News Archive 2021News Archive 2020News Archive 2019News Archive 2018News Archive 2015-2017AnalysisQnalysisPlayersPublic CompaniesPrivate/Startup CompaniesUniversitiesGovernment/Non-ProfitVenture CapitalVenture Capital – Sorted by Quantum CompanyResourcesConferencesToolsOther Websites and Industry AssociationsEducationBooksScorecardsGate Level Software PlatformsIBM Qiskit, Rigetti Forest, Microsoft QDK, Project QReview of the Cirq Quantum Software FrameworkQubit Implementation DashboardQubit CountQubit QualityQubit TechnologySoftware/Startup PartnersCloud Platform Hardware PartnersPodcastsAboutQCR Alerts Sign-Up FormAdvertising InquiriesQCR in the NewsContactPrivacy PolicyMembership
Quantinuum, NVIDIA, and Pfizer Validate Generative Quantum AI (GenQAI) Framework for Pharmaceutical R&D
Researchers from Quantinuum, NVIDIA, and Pfizer Inc. have validated a Generative Quantum AI (GenQAI) framework designed to automate and accelerate quantum circuit synthesis for pharmaceutical research and electronic structure modeling. In their paper, “Learning to Prepare Molecular Ground States with Transformer Models“, the hybrid architecture combines classical High-Performance Computing (HPC), generative transformer models, and quantum processing units (QPUs) to compute ground-state preparation circuits for complex active pharmaceutical ingredients (APIs).
